Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.

Mogensen UM, Andersson C, Fosbøl EL, Schramm TK, Vaag A, Scheller NM, Torp-Pedersen C, Gislason G, Køber L.

Diabetes Res Clin Pract. 2015 Jan;107(1):104-12. doi: 10.1016/j.diabres.2014.09.047. Epub 2014 Oct 7.

PMID:
25458330
2.

Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study.

Mogensen UM, Andersson C, Fosbøl EL, Schramm TK, Vaag A, Scheller NM, Torp-Pedersen C, Gislason G, Køber L.

Diabetologia. 2015 Jan;58(1):50-8. doi: 10.1007/s00125-014-3372-z. Epub 2014 Sep 10.

PMID:
25205223
3.

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study.

Mogensen UM, Andersson C, Fosbøl EL, Schramm TK, Vaag A, Scheller NM, Torp-Pedersen C, Gislason G, Køber L.

Diabetes Obes Metab. 2014 Oct;16(10):1001-8. doi: 10.1111/dom.12314. Epub 2014 Jun 9.

PMID:
24827939
4.

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosbøl EL, Køber L, Norgaard ML, Madsen M, Hansen PR, Torp-Pedersen C.

Eur Heart J. 2011 Aug;32(15):1900-8. doi: 10.1093/eurheartj/ehr077. Epub 2011 Apr 6. Erratum in: Eur Heart J. 2012 May;33(10):1183.

PMID:
21471135
5.

Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006.

Norgaard ML, Andersson C, Hansen PR, Andersen SS, Vaag A, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Gislason GH.

Cardiovasc Diabetol. 2011 Jan 19;10:5. doi: 10.1186/1475-2840-10-5.

6.

Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.

Bretler DM, Hansen PR, Abildstrøm SZ, Jørgensen CH, Sørensen R, Hansen ML, Schramm TK, Løkkegaard E, Torp-Pedersen C, Gislason GH.

Br J Clin Pharmacol. 2011 Jan;71(1):105-15. doi: 10.1111/j.1365-2125.2010.03790.x.

7.

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.

Jørgensen CH, Gislason GH, Andersson C, Ahlehoff O, Charlot M, Schramm TK, Vaag A, Abildstrøm SZ, Torp-Pedersen C, Hansen PR.

Cardiovasc Diabetol. 2010 Sep 16;9:54. doi: 10.1186/1475-2840-9-54.

8.

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study.

Andersson C, Olesen JB, Hansen PR, Weeke P, Norgaard ML, Jørgensen CH, Lange T, Abildstrøm SZ, Schramm TK, Vaag A, Køber L, Torp-Pedersen C, Gislason GH.

Diabetologia. 2010 Dec;53(12):2546-53. doi: 10.1007/s00125-010-1906-6. Epub 2010 Sep 14.

PMID:
20838985
9.

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

Hansen ML, Sørensen R, Clausen MT, Fog-Petersen ML, Raunsø J, Gadsbøll N, Gislason GH, Folke F, Andersen SS, Schramm TK, Abildstrøm SZ, Poulsen HE, Køber L, Torp-Pedersen C.

Arch Intern Med. 2010 Sep 13;170(16):1433-41. doi: 10.1001/archinternmed.2010.271.

PMID:
20837828
10.

Glyburide increases risk in patients with diabetes mellitus after emergent percutaneous intervention for myocardial infarction--a nationwide study.

Jørgensen CH, Gislason GH, Bretler D, Sørensen R, Norgaard ML, Hansen ML, Schramm TK, Abildstrom SZ, Torp-Pedersen C, Hansen PR.

Int J Cardiol. 2011 Nov 3;152(3):327-31. doi: 10.1016/j.ijcard.2010.07.027. Epub 2010 Aug 24.

PMID:
20797803
11.

Differences between out-of-hospital cardiac arrest in residential and public locations and implications for public-access defibrillation.

Folke F, Gislason GH, Lippert FK, Nielsen SL, Weeke P, Hansen ML, Fosbøl EL, Andersen SS, Rasmussen S, Schramm TK, Køber L, Torp-Pedersen C.

Circulation. 2010 Aug 10;122(6):623-30. doi: 10.1161/CIRCULATIONAHA.109.924423. Epub 2010 Jul 26.

PMID:
20660807
12.

Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals.

Fosbøl EL, Folke F, Jacobsen S, Rasmussen JN, Sørensen R, Schramm TK, Andersen SS, Rasmussen S, Poulsen HE, Køber L, Torp-Pedersen C, Gislason GH.

Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):395-405. doi: 10.1161/CIRCOUTCOMES.109.861104. Epub 2010 Jun 8.

PMID:
20530789
13.

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study.

Norgaard ML, Andersen SS, Schramm TK, Folke F, Jørgensen CH, Hansen ML, Andersson C, Bretler DM, Vaag A, Køber L, Torp-Pedersen C, Gislason GH.

Diabetologia. 2010 Aug;53(8):1612-9. doi: 10.1007/s00125-010-1783-z. Epub 2010 May 9.

PMID:
20454950
14.

Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study.

Bonde L, Sorensen R, Fosbøl EL, Abildstrøm SZ, Hansen PR, Kober L, Schramm TK, Bretler DM, Weeke P, Olesen J, Torp-Pedersen C, Gislason GH.

J Am Coll Cardiol. 2010 Mar 30;55(13):1300-7. doi: 10.1016/j.jacc.2009.11.057.

15.

National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark.

Dominguez H, Schramm TK, Gislason GH, Norgaard ML, Raunsø J, Abildstrøm SZ, Kober L, Poulsen HE, Torp-Pedersen CT.

Front Pharmacol. 2010 Dec 20;1:142. doi: 10.3389/fphar.2010.00142. eCollection 2010.

16.

Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006.

Dominguez H, Schramm TK, Norgaard ML, Abildstrøm SZ, Kober L, Jørgensen C, Guterbaum TJ, Poulsen HE, Torp-Pedersen C, Gislason GH.

Open Cardiovasc Med J. 2009 Nov 12;3:152-9. doi: 10.2174/1874192400903010152.

17.

Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used.

Fosbøl EL, Gislason GH, Poulsen HE, Hansen ML, Folke F, Schramm TK, Olesen JB, Bretler DM, Abildstrøm SZ, Sørensen R, Hvelplund A, Køber L, Torp-Pedersen C.

Circ Heart Fail. 2009 Nov;2(6):582-90. doi: 10.1161/CIRCHEARTFAILURE.109.851246. Epub 2009 Sep 22.

PMID:
19919983
18.

Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations.

Folke F, Lippert FK, Nielsen SL, Gislason GH, Hansen ML, Schramm TK, Sørensen R, Fosbøl EL, Andersen SS, Rasmussen S, Køber L, Torp-Pedersen C.

Circulation. 2009 Aug 11;120(6):510-7. doi: 10.1161/CIRCULATIONAHA.108.843755. Epub 2009 Jul 27.

PMID:
19635969
19.

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.

Andersen SS, Hansen ML, Gislason GH, Schramm TK, Folke F, Fosbøl E, Abildstrøm SZ, Madsen M, Køber L, Torp-Pedersen C.

Europace. 2009 Jul;11(7):886-91. doi: 10.1093/europace/eup119. Epub 2009 May 14.

PMID:
19443433
20.

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.

Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbøl EL, Sørensen R, Folke F, Buch P, Gadsbøll N, Rasmussen S, Poulsen HE, Køber L, Madsen M, Torp-Pedersen C.

Arch Intern Med. 2009 Jan 26;169(2):141-9. doi: 10.1001/archinternmed.2008.525.

PMID:
19171810

Supplemental Content

Loading ...
Support Center